Erin Copeland currently serves as the court-appointed Lead of the Paragard (birth control) MDL pending in the Northern District of Georgia and Co-Lead of the Suboxone MDL pending in the Northern District of Ohio. She serves on the Plaintiffs’ Steering Committee of the Hair Relaxer MDL pending in the Northern District of Illinois.
Previously, from 2017 to 2022, Erin served on the Executive Committee for the Essure consolidated state litigation in California, where she and her team oversaw the claims of thousands of women who suffered severe and permanent injuries as a result of the Essure permanent sterilization birth control device. In August 2020, she helped to negotiate a $1.6 billion settlement with Bayer to resolve the Essure litigation. Erin also served on the Plaintiffs’ Steering Committee for the various female pelvic mesh MDLs pending in the Southern District of West Virginia as well as the Pradaxa litigation pending in the Southern District. In the Pradaxa litigation, Erin served as State-Federal Liaison Counsel to the cases pending in St. Clair County, Illinois.
Erin is often invited to speak on a variety of legal issues at both judicial and general legal conferences. She also serves on the board of several legal organizations, including the American Association for Justice and Texas Women Rainmakers.
Erin is a native Houstonian who practices with the Houston-based law firm Fibich Leebron Copeland & Briggs. Erin and her family split time between Houston and Colorado where her son was a competitive snowboarder before attending golf school.
